|
1
|
Adams LA, Lymp JF, St Sauver J, Sanderson
SO, Lindor KD, Feldstein A and Angulo P: The natural history of
nonalcoholic fatty liver disease: A population-based cohort study.
Gastroenterology. 129:113–121. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Angulo P: Nonalcoholic fatty liver
disease. N Engl J Med. 346:1221–1231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clark JM: The epidemiology of nonalcoholic
fatty liver disease in adults. J Clin Gastroenterol. 40:(Suppl 1).
S5–S10. 2006.PubMed/NCBI
|
|
4
|
Ekstedt M, Franzén LE, Mathiesen UL,
Thorelius L, Holmqvist M, Bodemar G and Kechagias S: Long-term
follow-up of patients with NAFLD and elevated liver enzymes.
Hepatology. 44:865–873. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Porepa L, Ray JG, Sanchez-Romeu P and
Booth GL: Newly diagnosed diabetes mellitus as a risk factor for
serious liver disease. CMAJ. 182:E526–E531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohsawa I, Ishikawa M, Takahashi K,
Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S
and Ohta S: Hydrogen acts as a therapeutic antioxidant by
selectively reducing cytotoxic oxygen radicals. Nat Med.
13:688–694. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayashida K, Sano M, Ohsawa I, Shinmura K,
Tamaki K, Kimura K, Endo J, Katayama T, Kawamura A, Kohsaka S, et
al: Inhalation of hydrogen gas reduces infarct size in the rat
model of myocardial ischemia-reperfusion injury. Biochem Biophys
Res Commun. 373:30–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fukuda KI, Asoh S, Ishikawa M, Yamamoto Y,
Ohsawa I and Ohta S: Inhalation of hydrogen gas suppresses hepatic
injury caused by ischemia/reperfusion through reducing oxidative
stress. Biochem Biophys Res Commun. 361:670–674. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buchholz BM, Kaczorowski DJ, Sugimoto R,
Yang R, Wang Y, Billiar TR, McCurry KR, Bauer AJ and Nakao A:
Hydrogen inhalation ameliorates oxidative stress in transplantation
induced intestinal graft injury. Am J Transplant. 8:2015–2024.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ohsawa I, Nishimaki K, Yamagata K,
Ishikawa M and Ohta S: Consumption of hydrogen water prevents
atherosclerosis in apolipoprotein E knockout mice. Biochem Biophys
Res Commun. 377:1195–1198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kajiyama S, Hasegawa G, Asano M, Hosoda H,
Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, et al:
Supplementation of hydrogen-rich water improves lipid and glucose
metabolism in patients with type 2 diabetes or impaired glucose
tolerance. Nutr Res. 28:137–143. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sato Y, Kajiyama S, Amano A, Kondo Y,
Sasaki T, Handa S, Takahashi R, Fukui M, Hasegawa G, Nakamura N, et
al: Hydrogen-rich pure water prevents superoxide formation in brain
slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem
Biophys Res Commun. 375:346–350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu Y, Ito M, Fujita Y, Ito M, Ichihara M,
Masuda A, Suzuki Y, Maesawa S, Kajita Y, Hirayama M, et al:
Molecular hydrogen is protective against 6-hydroxydopamine-induced
nigrostriatal degeneration in a rat model of Parkinson's disease.
Neurosci Lett. 453:81–85. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kamimura N, Nishimaki K, Ohsawa I and Ohta
S: Molecular hydrogen improves obesity and diabetes by inducing
hepatic FGF21 and stimulating energy metabolism in db/db mice.
Obesity (Silver Spring). 19:1396–1403. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Garber J, Barbee R, Bielitzki J, Clayton
L, Donovan J, Hendriksen C, Kohn D, Lipman N, Locke P, Melcher J,
et al: Guide for the Care and Use of Laboratory Animals. 8th.
Washington (DC): National Academies Press (US); 2011, PubMed/NCBI
|
|
17
|
Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J,
Hou YJ, Chang YX, Tu QQ, Feng GS, et al: Nuclear factor
high-mobility group box 1 mediating the activation of Toll-like
receptor 4 signaling in hepatocytes in the early stage of
nonalcoholic fatty liver disease in mice. Hepatology. 54:1620–1630.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nugent DA, Smith DM and Jones HB: A review
of islet of Langerhans degeneration in rodent models of type 2
diabetes. Toxicol Pathol. 36:529–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agwaya MS, Vuzi PC and Nandutu AM:
Hypoglycemic activity of aqueous root bark extract zanthoxylum
chalybeum in alloxan-induced diabetic rats. J Diabetes Res.
2016:87275902016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
De Oliveira JC, Ludemann Camargo R,
Barella LF, Chaves Souto Branco R, Gravena C, Grassiolli S,
Torrezan R and De Cezar Freitas Mathias P: Anesthetic-induced
transient hyperglycemia and insulin resistance do not depend on the
sympathoadrenal axis. Minerva Endocrinol. 38:379–388.
2013.PubMed/NCBI
|
|
21
|
Shi J, Yao F, Zhong C, Pan X, Yang Y and
Lin Q: Hydrogen saline is protective for acute lung
ischaemia/reperfusion injuries in rats. Heart Lung Circ.
21:556–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brunt EM, Janney CG, Di Bisceglie AM,
Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis: A
proposal for grading and staging the histological lesions. Am J
Gastroenterol. 94:2467–2474. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Knodell RG, Ishak KG, Black WC, Chen TS,
Craig R, Kaplowitz N, Kiernan TW and Wollman J: Formulation and
application of a numerical scoring system for assessing
histological activity in asymptomatic chronic active hepatitis.
Hepatology. 1:431–435. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee GS, Yan JS, Ng RK, Kakar S and Maher
JJ: Polyunsaturated fat in the methionine-choline-deficient diet
influences hepatic inflammation but not hepatocellular injury. J
Lipid Res. 48:1885–1896. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhai X, Chen X, Shi J, Shi D, Ye Z, Liu W,
Li M, Wang Q, Kang Z, Bi H and Sun X: Lactulose ameliorates
cerebral ischemia-reperfusion injury in rats by inducing hydrogen
by activating Nrf2 expression. Free Radic Biol Med. 65:731–741.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Day CP and James OF: Steatohepatitis: A
tale of two ‘hits’? Gastroenterology. 114:842–845. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leite NC, Villela-Nogueira CA, Cardoso CR
and Salles GF: Non-alcoholic fatty liver disease and diabetes: From
physiopathological interplay to diagnosis and treatment. World J
Gastroenterol. 20:8377–8392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cai J, Kang Z, Liu K, Liu W, Li R, Zhang
JH, Luo X and Sun X: Neuroprotective effects of hydrogen saline in
neonatal hypoxia-ischemia rat model. Brain Res. 1256:129–137. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Suzuki H, Kayama Y, Sakamoto M, Iuchi H,
Shimizu I, Yoshino T, Katoh D, Nagoshi T, Tojo K, Minamino T, et
al: Arachidonate 12/15-lipoxygenase-induced inflammation and
oxidative stress are involved in the development of Diabetic
Cardiomyopathy. Diabetes. 64:618–630. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim MJ and Kim HK: Anti-diabetic effects
of electrolyzed reduced water in streptozotocin-induced and genetic
diabetic mice. Life Sci. 79:2288–2292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao X, Xue J, Wang XL, Zhang Y, Deng M
and Xie ML: Involvement of hepatic peroxisome
proliferator-activated receptor α/γ in the therapeutic effect of
osthole on high-fat and high-sucrose-induced steatohepatitis in
rats. Int Immunopharmacol. 22:176–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Konig B, Koch A, Spielmann J, Hilgenfeld
C, Hirche F, Stangl GI and Eder K: Activation of PPARalpha and
PPARgamma reduces triacylglycerol synthesis in rat hepatoma cells
by reduction of nuclear SREBP-1. Eur J Pharmacol. 605:23–30. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stienstra R, Mandard S, Patsouris D, Maass
C, Kersten S and Muller M: Peroxisome proliferator-activated
receptor alpha protects against obesity-induced hepatic
inflammation. Endocrinology. 148:2753–2763. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim JC, Lee YH, Yu MK, Lee NH, Park JD,
Bhattarai G and Yi HK: Anti-inflammatory mechanism of PPARγ on
LPS-induced pulp cells: Role of the ROS removal activity. Arch Oral
Biol. 57:392–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Inoue I, Goto S, Matsunaga T, Nakajima T,
Awata T, Hokari S, Komoda T and Katayama S: The ligands/activators
for peroxisome proliferator-activated receptor alpha (PPARalpha)
and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease
p22phox message expressions in primary endothelial cells.
Metabolism. 50:3–11. 2001. View Article : Google Scholar : PubMed/NCBI
|
